3-(4-oxo-4-(1,2,3,4-tetrahydroisoquinolin-7-ylamino)butanamido)-3-p-tolylpropanoic acid hydrochloride

ID: ALA1208850

Chembl Id: CHEMBL1208850

PubChem CID: 49862018

Max Phase: Preclinical

Molecular Formula: C23H28ClN3O4

Molecular Weight: 409.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(C(CC(=O)O)NC(=O)CCC(=O)Nc2ccc3c(c2)CNCC3)cc1.Cl

Standard InChI:  InChI=1S/C23H27N3O4.ClH/c1-15-2-4-17(5-3-15)20(13-23(29)30)26-22(28)9-8-21(27)25-19-7-6-16-10-11-24-14-18(16)12-19;/h2-7,12,20,24H,8-11,13-14H2,1H3,(H,25,27)(H,26,28)(H,29,30);1H

Standard InChI Key:  WVNJYGNOECSHLP-UHFFFAOYSA-N

Associated Targets(Human)

ITGB3 Tclin Integrin alpha-3/beta-3 (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 409.49Molecular Weight (Monoisotopic): 409.2002AlogP: 2.69#Rotatable Bonds: 8
Polar Surface Area: 107.53Molecular Species: ZWITTERIONHBA: 4HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 4.30CX Basic pKa: 8.62CX LogP: -0.41CX LogD: -0.43
Aromatic Rings: 2Heavy Atoms: 30QED Weighted: 0.54Np Likeness Score: -0.73

References

1. Krysko AA, Krysko OL, Kabanova TA, Andronati SA, Kabanov VM..  (2010)  Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin.,  20  (15): [PMID:20598885] [10.1016/j.bmcl.2010.06.051]

Source